...) levels in UC patients in clinical remission and at risk of relapse. Methods: This multicenter study comprised a double-blind, randomized, placebo-controlled phase (part I) and an open-label, non-randomized phase (part II). Eligible participants with UC in clinical remission treated with 5-aminosalicylic...

..., Szalay F, Färkkilä M, Pröls M, Strassburg CP; European AIH-BUC-Study Group: Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology 2010;139:1198-1206. 5. Dhaliwal HK, Anderson R, Thornhill EL, Schneider S, McFarlane...

... a worse longer-term outcome. (3) A higher initial prednisolone dose (1 mg/kg/day) plus azathioprine achieved 76% serum transaminase normalisation after 6 months but needs longer-term evaluation. (4) Histological remission (minimal hepatitis on re-biopsy) lags behind transaminase normalisation by 6-12...

...Kim L. Isaacs The major goal of therapy in inflammatory bowel disease is to induce remission. Remission has multiple definitions – clinical remission, where the patient’s symptoms have remitted, and endoscopic remission, in which there has been complete mucosal healing. Mucosal healing is a harder...

... patient is in understanding the options and being able to apply an individualized regimen based upon unique patient and disease factors. Crohn’s disease Induction Remission © 2010 S. Karger AG, Basel 2010 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...

...Christian P. Strassburg First described in 1950, autoimmune hepatitis (AIH) was the first chronic liver disease with a favorable response to drug therapy and a dismal prognosis when left untreated. In the decades since the first treatment studies, the basic strategy of inducing remission...